BioMarin Announces EMA Grants Accelerated Assessment for Cerliponase Alfa, Experimental Treatment for a Form of Batten Disease
BioMarin Receives European Orphan Drug Designation for BMN 270, First Investigational AAV-Factor VIII Gene Therapy for Patients with Hemophilia A
IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Kimberly Ann, CEO of Lahontan Gold Corp.
Skyharbour's Partner Company UraEx Resources Commences Summer 2025 Drilling Program at South Dufferin Uranium Project, Athabasca Basin, Saskatchewan
Sranan Gold Announces Investor Webinar on Exploration Activities at the Tapanahony Project in Suriname
